Indeed, our findings demonstrate that PRLR expression in breast cancer is indispensable in deriving both luminal and epithelial differentiation necessary to suppress stemness and diverse features of cancer aggressiveness and highlight PRLR as a pro/forward-differentiation therapeutic target in breast cancer. The gene discussed is PRLR; the disease is breast cancer.